Pablo Tebas
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV-related health complications and treatments, HIV/AIDS Research and Interventions, Immune Cell Function and Interaction
Most-Cited Works
- → Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV(2014)1,335 cited
- → Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy(2000)541 cited
- → Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202(2011)495 cited
- → Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption(2016)467 cited
- → Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1(2015)465 cited
- → Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers(2010)401 cited
- → Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial(2017)370 cited
- → Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection(2008)359 cited
- → Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021(2021)357 cited
- → Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study(2014)325 cited